Base de données de recherche subventionnée canadienne sur la COVID-19

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 671 through 680 of 734 results (Download Results)

Show results per page

COVID-19 Variant Network – Point of Care Heart-Lung Imaging for Patients Presenting with COVID‑19 Symptoms: Artificial Intelligence Precision Modeling for Prediction of Outcomes

Tsang, Teresa S | University of British Columbia | Operating Grant | $100,000

CIHR British Columbia 2021

Enhancing Indigenous Health as a result of the COVID‑19 Pandemic: Developing Indigenous Patient Experience Indicators of High Quality Virtual Primary Care

Roach, Pamela Marie | The University of Calgary | Other | $199,321

CIHR Alberta 2021

Social Isolation and Cognitive Function in Middle-aged and Older Adults: A Prospective Analysis of the Canadian Longitudinal Study on Aging

Oremus, Mark | University of Waterloo | Project Grant | $195,075

CIHR Ontario 2021

COVID-19 Variant Supplement – Development of a novel DC-targeting vaccine that targets COVID‑19 spike protein to control COVID‑19 infection

Yao, Xiao-Jian | University of Manitoba | Operating Grant | $50,000

CIHR Manitoba 2021

Enhancing culturally-safe ways for community wholistic health and wellness aspirations during COVID-19.

Warburton, Darren E | University of British Columbia | Other | $99,324

CIHR British Columbia 2021

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.

Moitessier, Nicolas R | McGill University | Operating Grant | $50,000

CIHR Quebec 2021

Unpacking COVID‑19 Vaccine Hesitancy in Canada

Dubé, Eve | Université Laval | Operating Grant | $499,870

CIHR Quebec 2021

Prevention of the immunopathology induced by SARS-CoV-2

Estaquier, Jérôme | Université Laval | Operating Grant | $499,800

CIHR Quebec 2021

Parental presence restrictions due to COVID-19: Examining impact and priorities for neonatal care (The PRESENCE Study)

Campbell-Yeo, Marsha L | Dalhousie University | Operating Grant | $193,100

CIHR Nova Scotia 2021

Determine how the interaction between SARS-CoV-2 spike protein and angiotensin-converting enzyme 2 (ACE2) affect viral spread and the severity of COVID‑19 outcomes.

Su, Ruey-Chyi | University of Manitoba | Operating Grant | $431,000

CIHR Manitoba 2021

Base de données de recherche subventionnée canadienne sur la COVID-19

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Network – Point of Care Heart-Lung Imaging for Patients Presenting with COVID‑19 Symptoms: Artificial Intelligence Precision Modeling for Prediction of Outcomes

Enhancing Indigenous Health as a result of the COVID‑19 Pandemic: Developing Indigenous Patient Experience Indicators of High Quality Virtual Primary Care

Social Isolation and Cognitive Function in Middle-aged and Older Adults: A Prospective Analysis of the Canadian Longitudinal Study on Aging

COVID-19 Variant Supplement – Development of a novel DC-targeting vaccine that targets COVID‑19 spike protein to control COVID‑19 infection

Enhancing culturally-safe ways for community wholistic health and wellness aspirations during COVID-19.

COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.

Unpacking COVID‑19 Vaccine Hesitancy in Canada

Prevention of the immunopathology induced by SARS-CoV-2

Parental presence restrictions due to COVID-19: Examining impact and priorities for neonatal care (The PRESENCE Study)

Determine how the interaction between SARS-CoV-2 spike protein and angiotensin-converting enzyme 2 (ACE2) affect viral spread and the severity of COVID‑19 outcomes.